Josiah K. Halm, M.D., M.S., FACP, FHM, CMQ
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Chair, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Professor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Chair, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2003 | Medical College of Wisconsin, Milwaukee, Wisconsin, US, Clinical Epidemiology, M.S |
| 1996 | University of Ghana Medical School, Accra, GH, Medicine, MB.chB |
Postgraduate Training
| 2014-2016 | Certificate Program in the Section of Integrated Ethics, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2006-2006 | 32nd Epidemiology and Prevention of Cardiovascular Disease, American Heart Association, Tahoe City, CA |
| 2001-2003 | Primary Care Research & Faculty Development, Medical College of Wisconsin, Milwaukee, Wisconsin |
| 1998-2001 | Residency, Internal Medicine, Cook County Hospital, Chicago, Illinois |
| 1996-1997 | Housemanship, Internal Medicine & Ob/Gyn, Korle-bu Teaching Hospital, Accra |
Licenses & Certifications
| 2026 | ACLS |
| 2026 | BLS |
| 2013 | The American Board of Medical Quality |
| 2008 | Texas Medical Board Physician License |
| 2007 | Georgia State Medical License |
| 2007 | California State Medical License |
| 2006 | New York State Medical License |
| 2001 | Wisconsin State Medical License |
| 2001 | American Board of Internal Medicine |
| 2001 | Diplomat, American Board of Internal Medicine (ABIM) |
| 1998 | Illinois State Medical License |
Experience & Service
Faculty Academic Appointments
Department Chair ad interim, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2024
Professor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2020
Associate Professor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2020
Clinical Specialist, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2020
Assistant Professor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2014
Administrative Appointments/Responsibilities
Clinical Medical Director, Clinical Decision Unit (CDU), The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2015
Director of Hospitalist Program, Aurora Sinai Medical Center, Milwaukee, WI, 2005 - 2008
Other Professional Positions
Adjunct Associate Professor, Department of Medicine, Baylor College of Medicine, Volunteer Clinical Faculty, Houston, TX, 2015 - 2018
Section Chief, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2020
Patient Safety Quality Officer, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2014
Hypertension Consultant, Point-One Software Company, WI, 2006 - 2007
Clinical Assistant Professor of Medicine, University of Wisconsin School of Medicine & Public Health, Milwaukee Clinical Campus, Milwaukee, WI, 2003 - 2008
Clinical Instructor of Medicine, Medical College of Wisconsin & Froedtert Memorial Lutheran Hospital, Milwaukee, WI, 2001 - 2003
Extramural Institutional Committee Activities
Member, Clinical Faculty Review Committee (CFRS), The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Provider Communications Advisory Board, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member (ex-officio), Committee on Faculty Awards, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Hospital at Home Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2024
Member, Cost of Care Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2023
Member, Institutional Pain Metrics Workgroup, The University of Texas MD Anderson Cancer Center, 2019 - Present
Divisional Representative, Physician Referral Services (PRS) Executive Council, The University of Texas MD Anderson Cancer Center, 2019 - 2020
Africa Committee Member, Global Academic Programs, The University of Texas MD Anderson Cancer Center, 2016 - 2020
Member, Institutional Patient Safety Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2020
Alternate Member, Accreditation Alternatives Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2015
Member, Clinical Effectiveness Committee, Order Sets Task Force, The University of Texas MD Anderson Cancer Center, 2013 - 2023
Member, Clinical Effectiveness Committee - CE Subcommittee, The University of Texas MD Anderson Cancer Center, 2013 - 2023
Member, Clinical Effectiveness Committee, Venous Thromboembolism (VTE) Treatment Algorithm Subcommittee, The University of Texas MD Anderson Cancer Center, 2013 - 2023
Member, Clinical Effectiveness Committee, Venous Thromboembolism (VTE) Prophylaxis Algorithm and Order Set Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2023
Alternate Member for Department Chair, Acute and Critical Care Services Subcommittee, The University of Texas MD Anderson Cancer Center, 2013 - 2015
Member, Sepsis Operational Priority Initiative, The University of Texas MD Anderson Cancer Center, 2012 - Present
Member, Admissions Review Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2013
Member, Quality Improvement Assessment Board (QIAB), The University of Texas MD Anderson Cancer Center, 2011 - 2021
Member, Ongoing Professional Practice Evaluation/Focus Professional Practice Evaluation (OPPE/FPPE) Quality Officers, The University of Texas MD Anderson Cancer Center, 2010 - 2020
Member, Division of Internal Medicine Quality Council, The University of Texas MD Anderson Cancer Center, 2009 - Present
Member, Institutional CV Committee, The University of Texas MD Anderson Cancer Center
Editorial Activities
Reviewer, Journal of palliative medicine, 2024 - Present
Reviewer, BMJ Open Journal, 2018 - Present
Clinical Vignettes for Society of General Internal Medicine Annual Meeting, Journal of General Internal Medicine, 2002
Professional Memberships
Selected Presentations & Talks
International Presentations
- 2025. Leveraging the ECHO (Extension for Community Healthcare Outcomes) Model to Improve Collaboration in Cancer Care: Impact, Innovations, and Future Directions in Africa. Invited. The Residency Training Collaboration Teams (RTCT), US.
Formal Peers
- 2020. Demonstrating Value: Oncology –“ Association of Reduced cost and Improved Quality with Implementation of a Value and Outcomes Driven Oncology-Hospitalist Collaboration”. Invited. Longview, TX, US.
- 2020. Medical Management of Oncology Patients Hospitalized Under Hospitalist Service. Visiting. Tyler, TX, US.
- 2019. Human Factors Engineering and Patient Safety. Invited. The Woodlands, TX, US.
- 2019. Capturing the full value of an Onco-Hospital Program - MD Anderson Experience Ten Year Review. Visiting. Toronto, CA.
- 2019. Role of Oncology-Hospitalist in the delivery of value based medical care for the hospitalized cancer patient. Visiting. Accra, GH.
- 2018. Organizing committee member. Invited. Moscow, RU.
- 2016. Quality Improvement - Developing a Quality Management Program for Hospitals in Ghana. Visiting. Accra, GH.
- 2015. Patient Safety - A framework for understanding, measuring and monitoring for safety in Ghana. Visiting. Accra, GH.
- 2012. Affordable Care Act. Invited. Houston, TX, US.
Grant & Contract Support
| Date: | 2015 - 2017 |
| Title: | Derivation and Validation of a Readmission Risk Scoring System in Cancer Patients |
| Funding Source: | University of Texas Healthcare and Effectiveness Quality of Care Grants Program |
| Role: | Co-PI |
| ID: | Grant 162291 |
| Date: | 2007 - 2008 |
| Title: | Double Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure [ASCEND-HF] |
| Funding Source: | Aurora Sinai Medical Center |
| Role: | PI |
| Date: | 2006 - 2007 |
| Title: | Acute decompensated heart failure registry - Adhere® Emergency Module: A multi-center open label observational study |
| Funding Source: | Aurora Sinai Medical Center |
| Role: | PI |
| Title: | Developing a model to enhance emotional wellbeing in adult oncology - NIH Grant #13086045, The University of Texas MD Anderson Cancer Center |
| Funding Source: | NIH |
| Role: | PI |
| ID: | Application No: 4430715 |
| Title: | External Validation of the Covid 19 Risk in Oncology Evaluation Tool |
| Funding Source: | CORONET validation |
| Role: | Collaborator |
| Title: | Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the Promoting Sleep |
| Funding Source: | Patient Engagement and Recovery (PROSPER) Project |
| Role: | Collaborator |
| Title: | The TEXAS Project: Transitions Explored and Studied: Leveraging Data to Prevent Readmissions in the TMC |
| Funding Source: | TMC Health Policy Institute Review Committee |
| Role: | Co-PI |
| Title: | Pul0942 in Reducing Infection Rate Progression to Covid 19. A Phase 2 Multiple Dose study to Evaluate the Efficacy and Safety of Uul0942 Inhalation Solution in Reducing the Infection Rate and Progression to Covid 19 in Adults Exposed to SAR CoV 2 |
| Funding Source: | IND# 148628 |
| Role: | Collaborator |
| ID: | IRB ID#2020-0407 |
| Title: | A Phase I study to Evaluate the Safety of Dose Escalation of Compound Kushen Injection (ZD023) in Lung/Head and Neck Patients receiving Stereotactic Body Radiation Therapy |
| Funding Source: | |
| Role: | Collaborator |
| ID: | Protocol 2021-000 |
| Title: | Expanded Access to Convalescent Plasma for the Treatment of Patients with Covid 19 |
| Funding Source: | |
| Role: | Collaborator |
| Title: | Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Covid 19 Related Acute Respiratory Distress Syndrome |
| Funding Source: | IND# 19950 |
| Role: | Collaborator |
| ID: | Phase I/II Protocol IRB 2020-0365 |
Selected Publications
Peer-Reviewed Articles
- Ali, N, Magnabosco, L, Soones, T, Chopra, DA, Gaeta, MS, Lin, Y, Ayanian, S, Pagali, S, Halm, J. External Validation of the Mayo Delirium Prediction Tool in Individuals With Cancer. Mayo Clinic Proceedings 101(4):592-599, 2026. e-Pub 2026. PMID: 41091088.
- Zhang, B, Alder, L, Rosner, S, Desai, A, Cooper, AJ, Yimer, HA, Bogdanska, W, Naqash, AR, Taylor, A, Joshi, U, Carlisle, JW, Champiat, S, Altan, M, Vega, MF, Halm, J, Manzano, JM, Fenton, G, Nie, Y, Wang, K, Parma, M, Rudin, CM, Chiang, A, Byers, LA, Gay, CM, Puri, S. A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS. Lung Cancer 211, 2026. e-Pub 2026. PMID: 41371100.
- Arthur, JA, Reddy, AS, Popat, UR, Halm, J, Vaughan-Adams, N, Myers, AL, Yang, P, De Moraes, AR, Laureano, R, Lopez-Quinones, I, Urbauer, D, Hui, D, Bruera, E. Abuse potential and analgesic efficacy of intravenous hydromorphone bolus administration among hospitalized patients with cancer pain. Cancer 131(3), 2025. e-Pub 2025. PMID: 39865340.
- Simbaqueba Clavijo, CA, Odaro, OE, Gandhi, A, Koom-Dadzie, K, Musaelyan, A, Dickson, KB, Chua, R, Bhise, VR, Amoateng, MD, Tomy, S, Leal Alviarez, DJ, Phyu, EM, Bogdanich, I, Andersen, C, Sheshadri, A, Palaskas, NL, Halm, J, Manzano, JM. Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers 17(3), 2025. e-Pub 2025. PMID: 39941771.
- Tanco K, Lopez G, Koyyalagunta L, Fellman B, Halm J, Ignatius J, Bruera E. Comparison of Health Care Providers Attitudes and Beliefs Regarding Medical Marijuana and Cannabidiol in the Management of Pain and Other Symptoms in Cancer Patients. J Palliat Med 26(4):539-543, 2023. e-Pub 2023. PMID: 36576904.
Review Articles
- Gandhi, A, Phyu, EM, Koom-Dadzie, K, Dickson, KB, Halm, J. GLP-1 Receptor Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic Disease. International journal of molecular sciences 27(6), 2026. e-Pub 2026. PMID: 41898712.
Abstracts
- Arine Musaelyan, Kodwo Dickson, Ayush Gandhi, Halm JK, Cesar Simbaqueba Clavijo. IMMUNOTHERAPY ASSOCIATED COLITIS IN HOSPITALIZED SOLID TUMORS PATIENTS RISK FACTORS. Multinational Association of Supportive Care in Cancer, 2026. e-Pub 2026.
- Escalante C, Zalpour A, Song J, Richardson M, Halm J, Yusuf S, S, Gao. Adverse Events of Rivaroxaban Usage in Cancer Patients. Internal Conference on Thrombosis & Hemostasis, Bergamo, Italy:S220-S221.
- Halm JK. Hospitalization Outcomes Among Patients with Confirmed and Suspected Covid 19 - D# CODE.
- Halm J. AKI and Clinical Outcomes on Cancer Patient with Normal Renal Function and Prior CKD who Acquired Covid 19 Infection. ASCO 2021.
- Manzano, F, Halm, J, et al. Evaluating the Impact of Oncology-Hospitalist Model of Inpatient Care on Unplanned 30-Day Readmissions Among Patients with Lung Cancer. 2017 NCCN 22nd Annual Conference, Orlando, FL.
Book Chapters
- Gonzalez, C, Halm J. Constipation in Cancer Patients. In: Oncologic Emergency Medicine. Springer Science.
- Halm J. Chapter 5: Acute Gastro-Intestinal Bleeding. In: Oncologic Emergencies. Springer Science.
Patient Reviews
CV information above last modified July 22, 2026